Recent Approaches to Targeting Canonical NF<i>κ</i>B Signaling in the Early Inflammatory Response to Renal IRI.

Abstract

Ischemia reperfusion injury (IRI) is the most common cause of in-hospital AKI and is associated with increased morbidity and mortality. IRI is associated with an early phase of inflammation primarily regulated by the canonical NF<i>κ</i>B signaling pathway. Despite recent advances in our understanding of the pathogenesis of IRI, few therapeutic strategies have emerged. The purpose of this manuscript is to review interventions targeting NF<i>κ</i>B after IRI.